Alere Inc $39.53

up +0.29


24/7/2014 10:58 AM  |  NYSE : ALR  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get ALR Trend Analysis - it has outperformed the S&P 500 by 22%

Partner Headlines

  1. UPDATE: Canaccord Genuity Reiterates On Alere On Positive Outlook

    Benzinga
  2. Alere Announces Plan for Initial Public Offering of Subsidiary BBI Diagnostics

    Benzinga
  3. UPDATE: JMP Securities Initiates Coverage on Alere on Multiple Positive ...

    Benzinga
  4. Private Capital Management Sells Update

    GuruFocus
  5. Performance - 11/15/2013

    GuruFocus
  6. Alere Announces Collaboration with UK National Health Service

    Benzinga
  7. Alere receives FDA Approval for Alere Determine™ HIV-1/2 Ag/Ab Combo

    Benzinga
  8. Alere Takes Steps To Enhance Board Of Directors And Governance Profile ...

    Benzinga
  9. Alere™ MobileLink Receives FDA Clearance

    Benzinga
  10. Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  11. Both Leading Proxy Advisors, ISS and Glass Lewis, Recommend a Vote to Elect ...

    Benzinga
  12. Alere's New, Independent Director Nominees Send Letter To Stockholders ...

    Benzinga
  13. US Stock Futures Slightly Lower Ahead Of Economic Data

    Benzinga
  14. Earnings Scheduled For February 15, 2013

    Benzinga
  15. Market Wrap for Monday, February 11: Little Changed in Quiet Trading Session

    Benzinga
  16. Benzinga's Top Downgrades

    Benzinga
  17. Microcap Man Chuck Royce Reveals Top New Stock Buys

    GuruFocus
  18. Microcap Man Chuck Royce Reveals Top New Buys

    GuruFocus
  19. Alere Buys Epocal for $166M

    Benzinga
  20. Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  21. Coach and Ralph Lauren Earnings Exposed to Yen Volatility

    GuruFocus
  22. Alere Hires Namal Nawana as COO

    Benzinga
  23. UPDATE: Wedbush Securities Upgrades Alere to Outperform

    Benzinga
  24. Highs & Lows: Alere, Apollo Group, and Verizon

    SchaeffersResearch
  25. Alere (ALR) Loses 14.3% on FDA Inspection, Possible Recall

    MarketIntelligenceCenter
  26. 5 Resilient Biotech Stocks to Buy for 2012

    GuruFocus
  27. Alere to Acquire eScreen for $270M

    Benzinga
  28. Seth Klarman Latest Portfolio: Buys IDIX, NG, ANV, Sells PDLI, ALR, BBEP

    GuruFocus
  29. UPDATE: Wedbush Lowers Price Target on Alere to $27

    Benzinga
  30. Wedbush Securities Maintains Alere at Neutral, Lowers PT from $31 to $27

    Benzinga
  31. Are Regional Banks Free from European Exposure?

    GuruFocus
  32. Alere Announces Negative Events at JP Morgan Health Conference

    Benzinga
  33. Alere Inc.: Foreign Currency Translations and the Euro

    GuruFocus
Trading Center